Coupling Polymorphism/Solvatomorphism and Physical Stability Evaluation with Early Salt Synthesis Optimization of an Investigational Drug
暂无分享,去创建一个
A. Shevchenko | I. Miroshnyk | J. Yliruusi | M. Mäkelä | V. Tanninen | A. Karjalainen | A. Tolvanen | Jorma Haarala | D. Belle | Saara Tiittanen
[1] J. Bernstein. Polymorphism − A Perspective , 2011 .
[2] George Zografi,et al. Accelerating proof of concept for small molecule drugs using solid-state chemistry. , 2010, Journal of pharmaceutical sciences.
[3] E. Kwong,et al. Strategies at the interface of drug discovery and development: early optimization of the solid state phase and preclinical toxicology formulation for potential drug candidates. , 2010, Journal of medicinal chemistry.
[4] Ashwini Nangia,et al. Conformational polymorphism in organic crystals. , 2008, Accounts of chemical research.
[5] Jukka Rantanen,et al. Hyphenated spectroscopy as a polymorph screening tool. , 2007, Journal of pharmaceutical and biomedical analysis.
[6] V. Caron,et al. Transformation of pharmaceutical compounds upon milling and comilling: the role of T(g). , 2007, Journal of pharmaceutical sciences.
[7] H. Brittain,et al. Polymorphism and solvatomorphism 2005. , 2007, Journal of pharmaceutical sciences.
[8] Stephen R Byrn,et al. Designing a molecular delivery system within a preclinical timeframe. , 2007, Drug discovery today.
[9] N. Urbanetz,et al. Quantifying the Degree of Disorder in Micronized Salbutamol Sulfate Using Moisture Sorption Analysis , 2007, Drug development and industrial pharmacy.
[10] Matt Peterson,et al. Application of high throughput technologies to drug substance and drug product development , 2004, Comput. Chem. Eng..
[11] S. Balbach,et al. Pharmaceutical evaluation of early development candidates "the 100 mg-approach". , 2004, International journal of pharmaceutics.
[12] Michael J Cima,et al. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids. , 2004, Advanced drug delivery reviews.
[13] W. Tong,et al. Impact of solid state properties on developability assessment of drug candidates. , 2004, Advanced drug delivery reviews.
[14] Orn Almarsson,et al. High-Throughput Surveys of Crystal Form Diversity of Highly Polymorphic Pharmaceutical Compounds , 2003 .
[15] G. Buckton,et al. A study of the crystallisation of amorphous salbutamol sulphate using water vapour sorption and near infrared spectroscopy. , 2002, International journal of pharmaceutics.
[16] Graham Buckton,et al. The use of gravimetric studies to assess the degree of crystallinity of predominantly crystalline powders , 1995 .
[17] A. Burger,et al. On the polymorphism of pharmaceuticals and other molecular crystals. I , 1979 .
[18] A. Burger,et al. On the polymorphism of pharmaceuticals and other molecular crystals. II , 1979 .
[19] F. Rappaport,et al. Über die Verwendung von Perjodat zur maßanalytischen Bestimmung von Ketosen (Monosacchariden) , 1937 .
[20] Jukka Rantanen,et al. Solid form screening--a review. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[21] Donald C. Monkhouse,et al. Review ArticlePharmaceutical Salts , 1977 .